Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Tea Consumption and Gastric Cancer: A Pooled Analysis From the Stomach Cancer Pooling (Stop) Project Consortium Publisher Pubmed



Martimianaki G1, 2 ; Alicandro G3, 4 ; Pelucchi C1 ; Bonzi R1 ; Rota M5 ; Hu J6 ; Johnson KC7 ; Rabkin CS8 ; Liao LM8 ; Sinha R8 ; Zhang ZF9 ; Dalmartello M1 ; Lunet N10, 11, 12 ; Morais S10, 11, 12 Show All Authors
Authors
  1. Martimianaki G1, 2
  2. Alicandro G3, 4
  3. Pelucchi C1
  4. Bonzi R1
  5. Rota M5
  6. Hu J6
  7. Johnson KC7
  8. Rabkin CS8
  9. Liao LM8
  10. Sinha R8
  11. Zhang ZF9
  12. Dalmartello M1
  13. Lunet N10, 11, 12
  14. Morais S10, 11, 12
  15. Palli D13
  16. Ferraroni M1
  17. Yu GP14
  18. Tsugane S15, 16
  19. Hidaka A15
  20. Curado MP17
  21. Diasneto E17
  22. Zaridze D18
  23. Maximovitch D18
  24. Vioque J19, 20
  25. Garcia De La Hera M19, 20
  26. Lopezcarrillo L21
  27. Hernandezramirez RU22
  28. Hamada GS23
  29. Ward MH8
  30. Mu L24
  31. Malekzadeh R25
  32. Pourfarzi F26
  33. Trichopoulou A2
  34. Karakatsani A2, 27
  35. Kurtz RC28
  36. Lagiou A29
  37. Lagiou P30, 31
  38. Boccia S32, 33
  39. Boffetta P34, 35
  40. Camargo MC8
  41. Negri E1, 35, 36
  42. La Vecchia C1
Show Affiliations
Authors Affiliations
  1. 1. Department of Clinical Sciences and Community Health, Branch of Medical Statistics, Biometry and Epidemiology “G.A. Maccacaro�, University of Milan, Milan, Italy
  2. 2. Hellenic Health Foundation, Athens, Greece
  3. 3. Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
  4. 4. Cystic Fibrosis Centre, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
  5. 5. Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
  6. 6. Harbin Medical University, Harbin, China
  7. 7. School of Epidemiology and Public Health, Department of Medicine, University of Ottawa, Ottawa, ON, Canada
  8. 8. Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, United States
  9. 9. Department of Epidemiology, UCLA Fielding School of Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, CA, United States
  10. 10. EPIUnit—Instituto de Saude Publica da Universidade do Porto, Porto, Portugal
  11. 11. Departamento de Ciencias da Saude Publica e Forenses e Educacao Medica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal
  12. 12. Laboratorio para a Investigacao Integrativa e Translacional em Saude Populacional (ITR), Porto, Portugal
  13. 13. Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, ISPRO, Florence, Italy
  14. 14. Medical Informatics Center, Peking University, Peking, China
  15. 15. Epidemiology and Prevention Group, Center for Public Health Sciences, National Cancer Center, Tokyo, Japan
  16. 16. National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition, Tokyo, Japan
  17. 17. Centro Internacional de Pesquisas, A.C. Camargo Cancer Center, Sao Paulo, Brazil
  18. 18. Department of clinical epidemiology, N.N. Blokhin National Medical Research Center for Oncology, Moscow, Russian Federation
  19. 19. Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain
  20. 20. Instituto de Investigacion Sanitaria y Biomedica de Alicante, Universidad Miguel Hernandez (ISABIAL-UMH), Alicante, Spain
  21. 21. Mexico National Institute of Public Health, Morelos, Mexico
  22. 22. Department of Biostatistics, Yale School of Public Health, Yale School of Medicine, New Haven, CT, United States
  23. 23. Nikkei Disease Prevention Center, Sao Paulo, Brazil
  24. 24. Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, United States
  25. 25. Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  26. 26. Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran
  27. 27. 2nd Pulmonary Medicine Department, National and Kapodistrian University of Athens, Medical School, “ATTIKON� University Hospital, Haidari, Greece
  28. 28. Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York, NY, United States
  29. 29. Department of Public and Community Health, School of Public Health, University of West Attica, Athens, Greece
  30. 30. Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
  31. 31. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States
  32. 32. Section of Hygiene, University Department of Life Sciences and Public Health, Universita Cattolica del Sacro Cuore, Roma, Italy
  33. 33. Department of Woman and Child Health and Public Health—Public Health Area, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
  34. 34. Stony Brook Cancer Center, Stony Brook University, Stony Brook, NY, United States
  35. 35. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
  36. 36. Pegaso Online University, Naples, Italy

Source: British Journal of Cancer Published:2022


Abstract

Background: Evidence from epidemiological studies on the role of tea drinking in gastric cancer risk remains inconsistent. We aimed to investigate and quantify the relationship between tea consumption and gastric cancer in the Stomach cancer Pooling (StoP) Project consortium. Methods: A total of 9438 cases and 20,451 controls from 22 studies worldwide were included. Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) of gastric cancer for regular versus non-regular tea drinkers were estimated by one and two-stage modelling analyses, including terms for sex, age and the main recognised risk factors for gastric cancer. Results: Compared to non-regular drinkers, the estimated adjusted pooled OR for regular tea drinkers was 0.91 (95% CI: 0.85–0.97). When the amount of tea consumed was considered, the OR for consumption of 1–2 cups/day was 1.01 (95% CI: 0.94–1.09) and for >3 cups/day was 0.91 (95% CI: 0.80–1.03). Stronger inverse associations emerged among regular drinkers in China and Japan (OR: 0.67, 95% CI: 0.49–0.91) where green tea is consumed, in subjects with H. pylori infection (OR: 0.68, 95% CI: 0.58–0.80), and for gastric cardia cancer (OR: 0.64, 95% CI: 0.49–0.84). Conclusion: Our results indicate a weak inverse association between tea consumption and gastric cancer. © 2022, The Author(s), under exclusive licence to Springer Nature Limited.
Other Related Docs
11. The Stomach Cancer Pooling (Stop) Project: Study Design and Presentation, European Journal of Cancer Prevention (2015)